Status:
NOT_YET_RECRUITING
Oct-A and Perimetry in Multiple Sclerosis
Lead Sponsor:
Assiut University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Brief Summary
This study aims to assess retinal vascular density using OCT-A and correlate these parameters with visual field changes in MS patients with and without a history of ON
Detailed Description
The aim of this work is to investigate the correlation between visual field parameters and optical coherence tomography angiography (OCT-A) findings in patients with multiple sclerosis (MS). MS is a c...
Eligibility Criteria
Inclusion
- Diagnosis of relapsing-remitting multiple sclerosis (RR-MS) or other MS subtypes confirmed by established neurological criteria. .Ability to undergo OCTA imaging and visual field testing. .Visual acuity sufficient to perform reliable visual field testing.
- Absence of other ocular diseases affecting the retina or optic nerve (e.g., diabetic retinopathy, glaucoma)
Exclusion
- .History of ocular diseases unrelated to MS that could confound OCTA or visual field results.
- .Recent optic neuritis episode within a defined period (often 3-6 months) to avoid acute inflammation effects.
- .Media opacities preventing quality OCTA imaging. .Systemic diseases that may affect retinal vasculature (e.g., uncontrolled hypertension, diabetes).
- .Poor cooperation or inability to complete visual field testing reliably
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT07175324
Start Date
September 1 2025
End Date
October 1 2026
Last Update
September 16 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.